Central Laboratories White Papers & Articles
-
The Impact Of Expert PK/PD Modeling In Psychedelic Research
12/2/2025
Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.
-
Modern Data Platform Strategies That Accelerate Clinical Development
11/26/2025
A modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.
-
The Real Cost In CNS Trials: Rater Drift And Site Readiness
11/21/2025
Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.
-
Open-Source Technologies Within Data Sciences Functional Outsourcing
11/21/2025
Accelerate innovation in clinical trials by embracing open-source technologies that enhance data analysis, improve scalability, and unlock advanced predictive and machine-learning capabilities.
-
The True Cost Of Tool Sprawl
11/17/2025
Tool sprawl in clinical trials creates hidden inefficiencies, fractured collaboration, and delayed insights. Unified systems restore flow, clarity, and control across research teams and functions.
-
De-Risking Schizophrenia Trials: Strategies For Improving Signal Detection
11/17/2025
Here, we summarize a recent webinar on the importance of integrating science-driven decision-making with proactive operational measures to safeguard both trial integrity and investment value in schizophrenia research.
-
Lost In Translation: Turning Multi-Omic Chaos Into Clinical Clarity
11/17/2025
Uncover how this integrated, science-focused approach helps sponsors navigate biological complexity, streamline timelines, and make data-driven decisions across a collection of therapy programs.
-
Biopharma Giant Streamlines Infrastructure With Proprietary Software
11/17/2025
Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.
-
Study Data Success: Expertise, Collaboration, And Transparency
11/14/2025
To strengthen cross-functional performance, teams should commit to building shared understanding, improving communication, and continuously refining their approach.
-
4 New Approvals In Q3 Across Gene, Cell, RNA Therapies
11/13/2025
Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.